The stock market closed with a mixed performance on Thursday, but beneath the surface, notable insider trades were unfolding.

Insider purchases can reveal a lot about the confidence of key personnel in a company’s future, potentially offering investors a chance to ride the coattails of those in the know. However, they should be considered just one of many factors when making investment decisions.

Let’s take a closer look at a couple of recent significant insider trades that may have an impact on the healthcare stock landscape.

Insider Bet on Dyne Therapeutics

• The Trade: Dyne Therapeutics, Inc. DYN saw 10% owner Dirk Kersten acquire 1,714,285 shares at an average price of $17.50, totaling a hefty $30 million investment.
• What’s Happening: Dyne Therapeutics recently publicly offered 17.15 million common stock at $17.50 per share, raising $300 million.
• What Dyne Therapeutics Does: Dyne Therapeutics Inc is a bio-technology company dedicated to developing therapeutics for patients with genetically driven diseases.

Insider Interest in EyePoint Pharmaceuticals

• The Trade: Significant shareholder Cormorant Global Healthcare Master Fund LP acquired 855,000 shares of EyePoint Pharmaceuticals, Inc. EYPT at an average price of $19.94, amounting to approximately $17.05 million.
• What’s Happening: EyePoint recently announced the dosing of the first patient in the Phase 2 VERONA clinical trial of EYP-1901 for diabetic macular edema.
• What EyePoint Pharmaceuticals Does: EyePoint Pharmaceuticals Inc is a pharmaceutical company focused on the development and commercialization of ophthalmic products for treating eye diseases.

Agree Realty Draws Insider Investment

• The Trade: Director and Executive Chairman of the Board Richard Agree bought 10,500 shares of Agree Realty Corporation ADC at an average price of $62.57, amounting to around $656,985.
• What’s Happening: Mizuho recently upgraded its outlook on Agree Realty from Neutral to a raised price target of $65.
• What Agree Realty Does: Agree Realty Corporation is a real estate investment trust primarily focused on owning, acquiring, developing, and managing retail properties leased to industry-leading tenants.

These transactions may be telling of the insiders’ optimism, potentially providing individual investors with additional considerations as they navigate the complex terrain of healthcare investments.